Recent Headlines
Within Biotechnology
Mercodia Will Market Their Oxidized LDL ELISA as an In-vitro Diagnostic for Clinical Use
The United States Food and Drug Administration (FDA) has determined that the Mercodia Oxidized LDL ELISA can be used clinically as an IVD. Oxidized LDL has been shown to play a key role in the initiation and progression of atherosclerosis, making the Mercodia Oxidized LDL ELISA a critical biomarker in cardiovascular disease-related studies and the most widely used method commercially available today. - September 27, 2010 - Mercodia Inc.
NSF Funds Research to Enable Distributed, Fair, and Privacy-Preserving Collaboration
Dr. Susanne Wetzel of Stevens Institute of Technology has been awarded a $457K research grant from the National Science Foundation to investigate privacy and security in the context of enabling collaboration. Dr. Wetzel’s successful proposal, “Distributed Privacy—Privacy-Preserving Policy Reconciliation,” supports core security research in the Department of Computer Science. - September 25, 2010 - Stevens Institute of Technology
Dr. Michael Bruno Appointed Chairman of Marine Board at the National Research Council
Dr. Michael Bruno, Dean of the Schaefer School of Engineering and Science at Stevens Institute of Technology, has been selected as Chairman of the Marine Board, under the auspices of the Transportation Research Board and the National Research Council. The Marine Board identifies and responds to critical issues in the area of water transportation, port engineering and management, marine policy, offshore development and operations, naval architecture, and maritime economics. - September 24, 2010 - Stevens Institute of Technology
Noesys Data Launches a New Data Service to Identify and Classify Arrhythmias in Safety Pharmacology Studies at 10th Annual Safety Pharmacology Society Meeting
During the annual meeting of the Safety Pharmacology Society in Boston Noesys Data unveiled a service that reviews cardiac safety study data for the occurrence of arrhythmia. A panel of Board Certified veterinary cardiologists to provide expert review and customer reports. - September 24, 2010 - Noesys Data
2010 BioWest Conference & Expo to Showcase 40+ New Technologies, Products and Services
More than 40 exhibitors will be showcasing new technology, products and services for 500+ attendees at the 2010 BioWest Conference & Expo, September 29 and 30, at the Grand Hyatt Denver, 1750 Welton. BioWest, in its eighth year, is the Rocky Mountain region’s preferred venue for visiting and learning about the bioscience industry. - September 23, 2010 - Colorado BioScience Association
Dr. Yi Guo Synchronizes Semiconductor Laser Arrays at Stevens with NSF Grant
The National Science Foundation has announced funding for Dr. Yi Guo’s research at Stevens into a rigorous mathematical approach to the analysis and control of coupled semiconductor laser systems using principles of collective behavior. - September 22, 2010 - Stevens Institute of Technology
Professor Souran Manoochehri of Stevens Elected ASME Fellow
Dr. Souran Manoochehri, Professor of Mechnical Engineering at Stevens Institute of Technology, has been selected a Fellow in the American Society of Mechanical Engineers. This prestigious honor recognizes significant achievements and contributions to the engineering profession. - September 22, 2010 - Stevens Institute of Technology
AnaSpec Introduces First FRET-Based Cathepsin B Assay
AnaSpec is pleased to announce the release of the SensoLyte® 520 Cathepsin B Activity Assay Kit, the industry’s first FRET-based kit for Cathepsin B. This homogeneous assay can be used for measuring Cathepsin B activity and for screening Cathepsin B inhibitors. The substrate employs in... - September 22, 2010 - AnaSpec, EGT Group
IonSense to Present Rapid Screening Solutions for Food Safety at the AOAC Annual Meeting and Exposition
DART MS Analyzes Targeted and Non-Targeted Contaminants in Seconds. - September 21, 2010 - IonSense, Inc.
Bioo Scientific Launched Color Endpoint Assays for In Vivo AST and LDH Analysis
Today Bioo Scientific launched the MaxDiscovery™ Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) Color Endpoint Assays for in vivo toxicity analysis. - September 16, 2010 - Bioo Scientific
AnaSpec Introduces Histone GO® Peptides
AnaSpec, the world’s largest provider of on-demand GO® peptides has introduced a wide selection of Histone H1, H2A, H2B, H3 and H4 peptides, especially the H3 peptides. The rapidly expanding Histone H3 GO ® Peptides include sequences that are acetylated, mono-, di- or tri-methylated,... - September 16, 2010 - AnaSpec, EGT Group
Stevens PhD Candidate Xi Chen Excels at International Structural Engineering Competition
Xi Chen, a Ph.D. candidate in the Department of Mechanical Engineering at Stevens Institute of Technology, took home second place in the structural health monitoring competition at the Asia-Pacific Summer School on Smart Structures Technology, held this year at Tokyo University in Japan. - September 16, 2010 - Stevens Institute of Technology
AnaSpec Introduces the Release of Mant-ATP and Mant-GTP
AnaSpec is pleased to announce the release of Mant-ATP and Mant-GTP. - September 14, 2010 - AnaSpec, EGT Group
Stevens Researchers Leverage Cryptography and Information Assurance to Re-Engineer Internet Architecture in Multi-University Collaboration Funded by NSF
Dr. Antonio Nicolosi, Assistant Professor of Computer Science at Stevens Institute of Technology is part of the interdisciplinary Nebula Project, a multi-university collaboration led by the University of Pennsylvania, which has recently been awarded a $7.5 million grant from the National Science... - September 14, 2010 - Stevens Institute of Technology
Four Finalists Selected for BioWest 2010 Venture Showcase Competition, Presenting Life-Changing Technologies
Cutting-edge development of a universal influenza vaccine, creation of an innovative hybridCpeptide manufacturing process, groundbreaking wastewater treatment through a new algae production system, and a revolutionary nontoxic surface treatment to control the growth of bacteria in hospitals, comprise the four finalists in this year’s BioWest Venture Showcase competition. - September 13, 2010 - Colorado BioScience Association
F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors
F2G Limited, the UK based antifungal drug discovery and development company, today announced the appointment of Dr Michael R. Hodges to the Company’s Board of Directors. Michael R Hodges, M.D., BSc., MRCP (UK) has 20 years of biopharmaceutical development experience and has worked in both... - September 13, 2010 - F2G Ltd
Synpromics: Scotland’s Latest Biotech Company
Synpromics announces its incorporation as Scotland’s latest biotech company. The new company aims to focus its activities in the area of synthetic biology and has acquired its patents from its managing director; Dr Michael Roberts. - September 12, 2010 - Synpromics Ltd
Stevens PhD Candidate Alicia Mahon is 2010 ASBPA Coastal Scholar
PhD candidate Alicia Mahon at Stevens has been named the American Shore and Beach Preservation Association 2010 ASBPA Coastal Scholar, which recognizes “a graduate student who aspires to advance his or her knowledge and experience of coastal or riverine science though an internship with ASBPA.” - September 12, 2010 - Stevens Institute of Technology
Colorado's Emmy® Award Winning Heroine Dr. Temple Grandin Keynotes CBSA Awards Dinner at 2010 BioWest Conference & Expo
General registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference & Expo, BioWest 2010. More than 700 participants are expected at this year’s event, September 29-30, at the Grand Hyatt (1750 Welton) in Denver. Headlining the Annual Awards Dinner during the 2010 BioWest Conference is Dr. Temple Grandin, noted author, speaker, scientist and autism expert who leads an impressive line up of national and international industry speakers and panelists. - September 07, 2010 - Colorado BioScience Association
Professor Andy Brick of Stevens Records Mafia II Soundtrack with Prague Filmharmonic
Professor Andy Brick, Distinguished Industry Associate Professor at Stevens Institute of Technology, was Supervising Orchestrator, Orchestral Music Director, and Orchestral Conductor for ground-breaking interactive game title Mafia II, released on August 24, 2010 for PS3, Xbox 360, and Windows PCs. - September 05, 2010 - Stevens Institute of Technology
Professor David Vaccari of Stevens Institute of Technology Receives AEESP Education Award
Dr. David Vaccari, associate professor at Stevens Institute of Technology, has recently been selected by the Association of Environmental Engineering and Science Professors (AEESP) to receive the organization’s 2010 educator award. Sponsored by John Wiley & Sons, Inc., the AEESP Award... - September 04, 2010 - Stevens Institute of Technology
Gene Logic Announces Appointment of Norrie Russell as President
Gene Logic, an Ocimum Biosolutions company announces the appointment of Norrie J. W. Russell, Ph. D., as the President of the company. With more than 30 years of experience in drug discovery, Dr. Russell has a long history of success driving innovation in pharmaceutical discovery and development. He also has experience leading entrepreneurial biotechnology companies, raising capital, and developing pioneering new technologies. - September 04, 2010 - ocimum biosolutions
Ocean Engineering Professor Jon Miller Receives ASCE Educator of the Year Award
American Society of Civil Engineers names Dr. Jon Miller of Stevens Institute of Technology the 2010 Educator of the Year for the North Jersey Branch. - September 02, 2010 - Stevens Institute of Technology
Wireless Networks Enable Intruder Detection and Emergency Alerts Funded by NSF
National Science Foundation funds Dr. Yingying Chen at Stevens Institute of Technology, in collaboration with Dr. Hui Xiong, Rutgers University, in research entitled: "NeTSE:Small:Collaborative Research: MILAN: Multi-Modal Passive Intrusion Learning in Pervasive Wireless Environments." - September 02, 2010 - Stevens Institute of Technology
National Institutes of Health Award a $1.7M SBIR Grant to MicroTransponder to Develop a Neurostimulation-Based Therapy to Treat Tinnitus
MicroTransponder, Inc., a privately-held medical device company, announced that it has been awarded a $1.7M SBIR grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) to develop a neurostimulation-based therapy for the treatment of Tinnitus. This project builds... - September 01, 2010 - MicroTransponder Inc.
AnaSpec Signs Distribution Agreement with Interprise Brasil
AnaSpec, Inc. and Interprise Brasil today announced a non-exclusive distributor agreement that will allow Interprise Brasil to distribute AnaSpec’s catalog and custom products throughout Brasil. - August 28, 2010 - AnaSpec, EGT Group
CW Optics Announces Clinical Trial of Breakthrough Technology for Wound Imaging for Diabetics
CW Optics, Inc. announced today a clinical trial at Richmond's Chippenham and Johnston-Willis (CJW) Medical Center to investigate the safety and efficacy of WoundImager®, an advanced optical imaging device for monitoring the effectiveness of therapeutic management of chronic wounds caused by... - August 27, 2010 - CW Optics, Inc.
CW Optics Announces Clinical Trial of Breakthrough Technology for the Detection of Intravenous Infiltration
CW Optics, Inc. announced today the launch of a clinical trial at the Virginia Commonwealth University Health System to investigate the safety and efficacy of ivWatch®, a novel optical device for monitoring intravenous (IV) infusion sites for infiltration. Each year, there are approximately 150... - August 27, 2010 - CW Optics, Inc.
Bio-Med QC Offers an Indiana Pharmacy Exclusive
Bio-Med QC has recently designed the most comprehensive and the most effective CSP quality assurance microbiology system available. The Bio-Shield AT system includes added value, on site training and saves you money over the alternative options that provide no microbiology support. Bio-Med QC has... - August 26, 2010 - Bio-Med QC
AnaSpec Visits with Noted Alzheimer’s Researcher, Dr. Patrick McGeer
AnaSpec’s general manager, Dr. Anita Hong and technical support specialist, Cecilia Po, visited the highly published and eminent Alzheimer’s researcher, Dr. Patrick McGeer and his associate, Dr. Jian-Ping Guo at the University of British Columbia, Vancouver, Canada on Aug. 12, 2010. - August 22, 2010 - AnaSpec, EGT Group
Strand and Narayana Hrudalaya Collaborate in Translational Cancer Research
First-of-its kind project in translational cancer research aimed to produce pioneering discoveries and affordable clinical solutions in cancer care. - August 21, 2010 - Strand Life Sciences Pvt. Ltd.
The Porcine microRNAome is Revealed
Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies - August 20, 2010 - LC Sciences LLC
AnaSpec Introduces SensoLyte® Biotin Quantitation Assay Kit
AnaSpec is pleased to announce the release of the FRET based biotin quantitation kit. The SensoLyte® Biotin Quantitation Assay Kit provides a convenient way to estimate the efficiency of biotinylation for biotin-protein conjugates. The kit also can be used in quantitate biotin concentration in a solution. - August 20, 2010 - AnaSpec, EGT Group
CHI’s BioPharma Strategy Series Presents the Inaugural Mitigating Safety Risks in Early Clinical Development Executive Forum November 8-9, 2010, Philadelphia, PA
Presentations Discuss Bridging the Gap Between Pre-Clinical and Clinical Safety to Improve Prediction. - August 20, 2010 - Cambridge Healthtech Institute
CEO Will Rosellini and MicroTransponder Inc. Named Finalists for the 10th Annual Tech Titans Awards
The MTBC has named CEO Will Rosellini a finalist for the Tech Innovator category and MicroTransponder a finalist for the Emerging Company Horizon category for the 10th Annual Tech Titan Awards in Texas. - August 17, 2010 - MicroTransponder Inc.
Bioo Scientific Chooses Eureka Genomics as Its Next-Generation Sequencing Provider
Bioo Scientific selected Eureka Genomics as its next-generation sequencing service provider. - August 17, 2010 - Bioo Scientific
Clinical Trials in Russia. 2nd Quarter 2010.
The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 178 new clinical trials of all types including local and bioequivalence studies during the second quarter of 2010 demonstrating a 38% increase over the corresponding period of last year. - August 14, 2010 - Synergy Research Group
AnaSpec Introduces Speedy 28-Day Antibody Service
AnaSpec introduces the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol uses a proprietary mixture of Freund's free immuno-stimulatory compounds. The first bleed, obtained at the accelerated rate of Day 21 after... - August 11, 2010 - AnaSpec, EGT Group
NSF Funds Innovative Approach to Biomimetic Nanofiber Bone Regeneration
Dr. Hongjun Wang at Stevens Institute of Technology investigates a new bottom-up approach to tissue engineering. - August 06, 2010 - Stevens Institute of Technology
Colorado BioScience Association Seeks Region’s Top Innovators for Venture Showcase Competition at 2010 BioWest Conference & Expo
The organizers of the annual BioWest Conference & Expo are again looking for the best bioscience start-ups in the region as candidates for this year's $7,500 Dorsey & Whitney Venture Showcase Award. Four companies will be chosen to present at the showcase on Wednesday, September 29, 2010, and will be judged by a panel of venture capitalists. Deadline for entry is Friday, August 20. - August 04, 2010 - Colorado BioScience Association
Novus Biologicals Releases Two New Posters to Guide Antibody Research
Novus revealed two new posters at the ISSCR 8th Annual Meeting between June 16 - 19 – a fluorescent labels poster and a stem cell signalling pathway poster. The fluorescent labels poster displays all fluorophores that Novus offers conjugated to their primary antibodies. The stem cell... - August 04, 2010 - Novus Biologicals Europe
NSF Funds Building a Creativity Collective: Using the Crowd to Solve Societal Problems
Stevens Professors Nickerson and Sakamoto are funded by the National Science Foundation to research crowdsourcing and the creative collective. - July 30, 2010 - Stevens Institute of Technology
International Stem Cell Corporation Planning European Subsidiary
International Stem Cell Corporation (OTCBB:ISCO) announced that it had entered into a Memorandum of Understanding with ARG Vermogensverwaltung AG ('ARG'), a German Investment Fund, to create a new European subsidiary ('ISCO Europe') to be funded with up to $10 million of capital derived from ARG... - July 28, 2010 - International Stem Cell Corporation
ALPCO Diagnostics Launches First Commercially Available Sclerostin ELISA in the U.S.
ALPCO Diagnostics recently launched an ELISA specific for measuring human sclerostin in serum and plasma. Sclerostin inhibits osteoblast activity via antagonism of the wnt signaling pathway and plays a key role in the regulation of bone formation. Reports show that sclerostin expression and/or... - July 27, 2010 - ALPCO
Bioo Scientific Releases the ExoMir™ Kit to Facilitate RNA Analysis in Cell-Free Fluids
Bioo Scientific’s new ExoMir™ kit simplifies the fractionation of and RNA extraction from exosomes and other microparticles in cell-free fluids. - July 26, 2010 - Bioo Scientific
Stevens Hosts 2010 Metro Area NEMS/MEMS Workshop
Nanomanufacturing Workshop hosted by Stevens Institute of Technology on Monday, July 26th in Hoboken, New Jersey. - July 24, 2010 - Stevens Institute of Technology
Health Decisions Appoints New CTO to Streamline Its HD360° Trial Management Platform
CRO hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information. - July 24, 2010 - Health Decisions
NSF Funds Infection-Resistant Orthopedic Research
Researchers at Stevens explore inkjet printing of drug-eluting, bioresorbable micropatterns onto the surface of orthopedic implants to prevent bacterial infection of the implants. - July 21, 2010 - Stevens Institute of Technology
AnaSpec’s Published References Pass 1000
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 1000. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - July 21, 2010 - AnaSpec, EGT Group
ALN Publishes Article on Whole Animal Database by Noesys Data
Article on Artios Software Suite is published by ALN, a respected industry publication covering animal research institutions and markets. - July 21, 2010 - Noesys Data